The detection of biomarkers in body fluids has major advantages over the use of tissue markers, which most often require invasive biopsies that can be difficult to perform and potentially dangerous. Discriminating between cargoes associated with extracellular vesicles in body fluids using different approaches could provide insight into disease staging.